Prognostic value of cardiac troponin-I or troponin-T elevation following nonemergent percutaneous coronary intervention: A meta-analysis

Catheterization and Cardiovascular Interventions

Volumn 77, Issue 7, 2011, Pages 1020-1030

  Feldman, Dmitriy N ^a   Kim, Luke ^a   Rene, A Garvey ^a   Minutello, Robert M ^a   Bergman, Geoffrey ^a   Wong, S Chiu ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

meta analysis; outcomes; percutaneous coronary intervention; troponin

Indexed keywords

CREATINE KINASE MB; FIBRINOGEN RECEPTOR ANTAGONIST; TROPONIN I; TROPONIN T;

ADVERSE OUTCOME; ARTICLE; CORONARY STENT; FOLLOW UP; HEART INFARCTION; HUMAN; MORTALITY; PATIENT MONITORING; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PROGNOSIS;

ANGIOPLASTY, BALLOON, CORONARY; BIOLOGICAL MARKERS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; STENTS; TIME FACTORS; TREATMENT OUTCOME; TROPONIN I; TROPONIN T; UP-REGULATION;

EID: 79958283225     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.22962     Document Type: Article

References (60)

1. Hamm CW, Goldmann BU, Heeschen C, Kreymann G, Berger J, Meinertz T,. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 1997; 337: 1648-1653. (Pubitemid 27510101)
2. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined-A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial infarction. J Am Coll Cardiol 2000; 36: 959-969.
3. Polanczyk CA, Lee TH, Cook EF, et al. Cardiac troponin I as a predictor of major cardiac events in emergency department patients with acute chest pain. J Am Coll Cardiol 1998; 32: 8-14.
4. Hamm CW, Ravkilde J, Gerhardt W, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med 1992; 327: 146-150.
5. Galvani M, Ottani F, Ferrini D, et al. Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. Circulation 1997; 95: 2053-2059. (Pubitemid 27184273)
6. Heidenreich PA, Alloggiamento T, Melsop K, McDonald KM, Go AS, Hlatky MA,. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: A meta-analysis. J Am Coll Cardiol 2001; 38: 478-485. (Pubitemid 32721777)
7. Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996; 335: 1342-1349. (Pubitemid 26360452)
8. Olatidoye AG, Wu AH, Feng YJ, Waters D,. Prognostic role of troponin T versus troponin I in unstable angina pectoris for cardiac events with meta-analysis comparing published studies. Am J Cardiol 1998; 81: 1405-1410. (Pubitemid 28283819)
9. Patti G, Colonna G, Pasceri V, Pepe LL, Montinaro A, Di Sciascio G,. Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: Results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study. Circulation 2005; 111: 2099-1106.
10. Ellis SG, Chew D, Chan A, Whitlow PL, Schneider JP, Topol EJ,. Death following creatine kinase-MB elevation after coronary intervention: Identification of an early risk period: Importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy. Circulation 2002; 106: 1205-1210. (Pubitemid 34988637)
11. Kini A, Marmur JD, Kini S, et al. Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: Implications for early discharge after coronary intervention. J Am Coll Cardiol 1999; 34: 663-671. (Pubitemid 29436169)
12. Abdelmeguid AE, Topol EJ, Whitlow PL, Sapp SK, Ellis SG,. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation 1996; 94: 1528-1536. (Pubitemid 26320254)
13. Dangas G, Mehran R, Feldman D, et al. Postprocedure creatine kinase-MB elevation and baseline left ventricular dysfunction predict one-year mortality after percutaneous coronary intervention. Am J Cardiol 2002; 89: 586-589. (Pubitemid 34178571)
14. Saucedo JF, Mehran R, Dangas G, et al. Long-term clinical events following creatine kinase-myocardial band isoenzyme elevation after successful coronary stenting. J Am Coll Cardiol 2000; 35: 1134-1141. (Pubitemid 30206886)
15. Akkerhuis KM, Alexander JH, Tardiff BE, et al. Minor myocardial damage and prognosis: Are spontaneous and percutaneous coronary intervention-related events different? Circulation 2002; 105: 554-556. (Pubitemid 34123427)
16. Attali P, Aleil B, Petitpas G, et al. Sensitivity and long-term prognostic value of cardiac troponin-I increase shortly after percutaneous transluminal coronary angioplasty. Clin Cardiol 1998; 21: 353-356. (Pubitemid 28196836)
17. Bertinchant JP, Polge A, Ledermann B, et al. Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris. Am J Cardiol 1999; 84: 51-57. (Pubitemid 29307640)
18. Fuchs S, Kornowski R, Mehran R, et al. Prognostic value of cardiac troponin-I levels following catheter-based coronary interventions. Am J Cardiol 2000; 85: 1077-1082. (Pubitemid 30214252)
19. Gruberg L, Fuchs S, Waksman R, et al. Prognostic value of cardiac troponin I elevation after percutaneous coronary intervention in patients with chronic renal insufficiency: A 12-month outcome analysis. Cathet Cardiovasc Intervent 2002; 55: 174-179. (Pubitemid 34127375)
20. Saadeddin SM, Habbab MA, Sobki SH, Ferns GA,. Biochemical detection of minor myocardial injury after elective, uncomplicated, successful percutaneous coronary intervention in patients with stable angina: Clinical outcome. Ann Clin Biochem 2002; 39: 392-397. (Pubitemid 34743641)
21. Cantor WJ, Newby LK, Christenson RH, et al.; SYMPHONY and 2nd SYMPHONY Cardiac Markers Substudy Investigators. Prognostic significance of elevated troponin I after percutaneous coronary intervention. J Am Coll Cardiol 2002; 39: 1738-1744. (Pubitemid 34595282)
22. Ricciardi MJ, Davidson CJ, Gubernikoff G, et al. Troponin I elevation and cardiac events after percutaneous coronary intervention. Am Heart J 2003; 145: 522-528. (Pubitemid 36390500)
23. Nallamothu BK, Chetcuti S, Mukherjee D, et al. Prognostic implication of troponin I elevation after percutaneous coronary intervention. Am J Cardiol 2003; 91: 1272-1274. (Pubitemid 36561401)
24. Ramirez-Morino A, Cardenal R, Pera C, et al. Predictors and prognostic value of myocardial injury following stent implantation. Int J Cardiol 2004; 97: 193-198. (Pubitemid 39286835)
25. Kini AS, Lee P, Marmur JD, et al. Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality. Am J Cardiol 2004; 93: 18-23. (Pubitemid 38022028)
26. Natarajan MK, Kreatsoulas C, Velianou JL, Mehta SR, Pericak D, Goodhart DM,. Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventions. Am J Cardiol 2004; 93: 750-753. (Pubitemid 38338569)
27. Cavallini C, Savonitto S, Violini R, et al. Italian " Atherosclerosis, thrombosis, and vascular biology" and "Society for Invasive Cardiology-GISE" Investigators. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: Results of the CK-MB and PCI study. Eur Heart J 2005; 26: 1494-1498. (Pubitemid 41373489)
28. Izgi A, Tanalp AC, Kirma C, et al. Predictors and prognostic significance of troponin-I release following elective coronary angioplasty. J Int Med Res 2006; 34: 612-623. (Pubitemid 46165385)
29. Okmen E, Cam N, Sanli A, Unal S, Tartan Z, Vural M,. Cardiac troponin after succesful percutaneous coronary angioplasty: Predictors and long-term prognostic value. Angiology 2006; 57: 161-169. (Pubitemid 44438568)
30. Gravning J, Ueland T, Mørkrid L, Endresen K, Aaberge L, Kjekshus J,. Different prognostic importance of elevated troponin I after percutaneous coronary intervention in acute coronary syndrome and stable angina pectoris. Scand Cardiovasc J 2008; 42: 214-221. (Pubitemid 351882330)
31. De Labriolle A, Lemesle G, Bonello L, et al. Prognostic significance of small troponin I rise after a successful elective percutaneous coronary intervention of a native artery. Am J Cardiol 2009; 103: 639-645.
32. Feldman DN, Minutello RM, Bergman G, Moussa I, Wong SC,. Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes. Am J Cardiol 2009; 104: 1210-1215.
33. Milani RV, Fitzgerald R, Milani JN, Lavie CJ,. The impact of micro troponin leak on long-term outcomes following elective percutaneous coronary intervention. Catheter Cardiovasc Interv 2009; 74: 819-822.
34. Shyu KG, Kuan PL, Cheng JJ, Hung CR,. Cardiac troponin T, creatine kinase, and its isoform release after succesful percutaneous transluminal coronary angioplasty with or without stenting. Am Heart J 1998; 135: 862-867.
35. Herrmann J, Von Birgelen C, Haude M, et al. Prognostic implication of cardiac troponin T increase following stent implantation. Heart 2002; 87: 549-553. (Pubitemid 34547979)
36. Kizer JR, Muttrej MR, Matthai WH, et al. Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention. Eur Heart J 2003; 24: 1314-1322. (Pubitemid 36917702)
37. Miller WL, Garrat KN, Burrit MF, Lennon RJ, Reeder GS, Jaffe AS,. Baseline troponin level: Key to understanding the importance of post-PCI troponin elevations. Eur Heart J 2006; 27: 1061-1069.
38. Prasad A, Singh M, Lerman A, Lennon RJ, Holmes DR, Rihal CS,. Isolated elevation in troponin T after percutaneous coronary intervention is associated with higher long-term mortality. J Am Coll Cardiol 2006; 48: 1765-1770. (Pubitemid 44648624)
39. Nienhuis MB, Ottervanger JP, Dikkeschei LD, et al. Prognostic importance of elevated troponin T and creatine kinase after elective percutaneous coronary intervention. Int J Cardiol 2007; 120: 242-247. (Pubitemid 47053880)
40. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF,. Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999; 354: 1896-1900.
41. Higgins JPT, Thompson SG, Deeks JJ, Altman DG,. Measuring inconsistency in meta-analysis. BMJ 2003; 327: 557-560.
42. Bax L, Yu LM, Ikeda N, Tsuruta H, Moons KGM,. Development and validation of MIX: Comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol 2006; 6: 50.
43. Bax L, Yu LM, Ikeda N, Tsuruta N, Moons KGM,. MIX: Comprehensive free software for meta-analysis of causal research data-Version 1.7.; 2008.
44. Wu AH, Boden WE, McKay RG,. Long-term follow-up of patients with increased cardiac troponin concentrations following percutaneous coronary intervention. Am J Cardiol 2002; 89: 1300-1302. (Pubitemid 34606894)
45. Nienhuis MB, Ottervanger JP, Bilo HJ, Dikkeschei BD, Zijlstra F,. Prognostic value of troponin after elective percutaneous coronary intervention: A meta-analysis. Catheter Cardiovasc Interv 2008; 71: 318-324. (Pubitemid 351428148)
46. Testa L, Van Gaal WJ, Biondi Zoccai GGL, et al. Myocardial infarction after percutaneous coronary intervention: A meta-analysis of troponin elevation applying the new universal definition. Q J Med 2009; 102: 369-378.
47. Mehran R, Dangas G, Mintz GS, et al. Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions: Intravascular ultrasound study of 2256 patients. Circulation 2000; 101: 604-610. (Pubitemid 30094730)
48. Bhatt DL, Topol EJ,. Periprocedural cardiac enzyme elevation predicts adverse outcomes. Circulation 2005; 112: 906-923.
49. Abbas SA, Glazier JJ, Wu AH, et al. Factors associated with the release of cardiac troponin T following percutaneous transluminal coronary angioplasty. Clin Cardiol 1996; 19: 782-786. (Pubitemid 26353131)
50. Kong TQ, Davidson CJ, Meyers SN, Parker MA, Bonow RO,. Prognostic implications of creatine kinase elevation following elective coronary interventions. JAMA 1997; 277: 461-466. (Pubitemid 27074329)
51. Gibson CM, Murphy SA, Marble SJ, et al. Relationship of creatine kinase-myocardial band release to thrombolysis in myocardial Infarction perfusion grade after intracoronary stent placement: An ESPRIT substudy. Am Heart J 2002; 143: 106-110. (Pubitemid 34056382)
52. Bhatt DL, Topol EJ, Cutlip DE, Kuntz RE,. Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Circulation 2005; 112: 906-922.
53. Chen WH, Lee PY, Ng W, Tse HF, Lau CP,. Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment. J Am Coll Cardiol 2004; 43: 1122-1126. (Pubitemid 38353000)
54. Saadeddin SM, Habbab MA, Sobki SH, Ferns GA,. Association of systemic inflammatory state with troponin I elevation after elective uncomplicated percutaneous coronary intervention. Am J Cardiol 2002; 89: 981-983. (Pubitemid 34310301)
55. Pasceri V, Patti G, Nusca A, Pristipino C, Richichi G, Di Sciascio G,. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: Results from the ARMYDA (Atorvastatin for Reduction of Myocardial Deamage during Angioplasty) study. Circulation 2004; 110: 674-678. (Pubitemid 39056265)
56. Selvanayagam JB, Porto I, Channon K, et al. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: Insights from cardiovascular magnetic resonance imaging. Circulation 2005; 111: 1027-1032. (Pubitemid 40354521)
57. Proudfit WJ, Bruschke AVG, MacMillan JP, Williams GW, Sones FM Jr,. Fifteen-year survival study of patients with obstructive coronary artery disease. Circulation 1983; 68: 986-997. (Pubitemid 14238475)
58. Kanaparti PK, Brown DL,. Relation between coronary atherosclerotic plaque burden and cardiac enzyme elevation following percutaneous coronary intervention. Am J Cardiol 2000; 86: 619-622.
59. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention-summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 2006; 47: 216-235. (Pubitemid 43005194)
60. Wang TY, Peterson ED, Dai D, et al. Patterns of cardiac marker surveillance after elective percutaneous coronary intervention and implications for the use of periprocedural myocardial infarction as a quality metric: A report from the National Cardiovascular Data Registry (NCDR). J Am Coll Cardiol 2008; 51: 2068-2074. (Pubitemid 351680519)